Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stem Cell Derived Exome for Treatment of Diabetic Foot
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Summary
This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.
Official title: Skin Drug Prepared From Stem Cell Derived Exome for Treatment of Diabetic Foot: a Phase II Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-08-01
Completion Date
2033-12-30
Last Updated
2024-06-28
Healthy Volunteers
No
Conditions
Interventions
Skin drug prepared with exome originated from stem cell
Skin drug prepared with exome originated from stem cell will be applied to patient with diabetic foot.
Locations (1)
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China